BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le-Carlson M, Seki S, Abarbanel D, Quiros A, Cox K, Nadeau KC. Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2013;56:257-62. [PMID: 23059644 DOI: 10.1097/MPG.0b013e3182758d49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Amber KT, Valdebran M, Kridin K, Grando SA. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease. Front Med (Lausanne) 2018;5:201. [PMID: 30042946 DOI: 10.3389/fmed.2018.00201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
2 Lingblom C, Bergquist H, Johnsson M, Sundström P, Quiding-Järbrink M, Bove M, Wennerås C. Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells. Inflammation 2014;37:1932-44. [PMID: 24870064 DOI: 10.1007/s10753-014-9926-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
3 Hill DA, Spergel JM. The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep 2016;16:9. [PMID: 26758862 DOI: 10.1007/s11882-015-0592-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
4 Lingblom C, Wallander J, Ingelsten M, Bergquist H, Bove M, Saalman R, Welin A, Wennerås C. Eosinophils from eosinophilic oesophagitis patients have T cell suppressive capacity and express FOXP3. Clin Exp Immunol 2017;187:455-65. [PMID: 27921303 DOI: 10.1111/cei.12898] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
5 Zhang Z, Sferra TJ, Eroglu Y. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci 2013;58:1497-506. [PMID: 23456499 DOI: 10.1007/s10620-013-2599-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kleuskens MTA, Haasnoot ML, Herpers BM, Ampting MTJV, Bredenoord AJ, Garssen J, Redegeld FA, van Esch BCAM. Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function. Allergy 2022;77:1510-21. [PMID: 34458999 DOI: 10.1111/all.15069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ghisa M, Savarino V, Buda A, Katzka DA, Savarino E. Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature. Therap Adv Gastroenterol 2022;15:175628482210768. [DOI: 10.1177/17562848221076888] [Reference Citation Analysis]
8 Oliva S, Azouz NP, Stronati L, Rothenberg ME. Recent advances in potential targets for eosinophilic esophagitis treatments. Expert Rev Clin Immunol 2020;16:421-8. [PMID: 32163308 DOI: 10.1080/1744666X.2020.1742110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, Taber T, Kaushal S, Limgala R, Brown M, Gupta R, Balba N, Goker-Alpan O, Khojah A, Alpan O. A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 2015;10:e0113483. [PMID: 25789989 DOI: 10.1371/journal.pone.0113483] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 11.0] [Reference Citation Analysis]
10 Dunn JLM, Caldwell JM, Ballaban A, Ben-Baruch Morgenstern N, Rochman M, Rothenberg ME. Bidirectional crosstalk between eosinophils and esophageal epithelial cells regulates inflammatory and remodeling processes. Mucosal Immunol 2021;14:1133-43. [PMID: 33972688 DOI: 10.1038/s41385-021-00400-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Rodríguez-Sánchez J, García Rojo M, López Viedma B, de la Santa Belda E, Palomar PO, Torrijos EG, López LG, Camacho JO. Accuracy of liquid cytology in the diagnosis and monitoring of eosinophilic oesophagitis. United European Gastroenterol J 2014;2:475-81. [PMID: 25452842 DOI: 10.1177/2050640614552315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 van Rhijn BD, Bredenoord AJ. Management of Eosinophilic Esophagitis Based on Pathophysiological Evidence. J Clin Gastroenterol 2017;51:659-68. [PMID: 28644315 DOI: 10.1097/MCG.0000000000000879] [Reference Citation Analysis]
13 Wechsler JB, Bryce PJ. Allergic mechanisms in eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43:281-296. [PMID: 24813516 DOI: 10.1016/j.gtc.2014.02.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
14 Caldwell JM, Paul M, Rothenberg ME. Novel immunologic mechanisms in eosinophilic esophagitis. Curr Opin Immunol 2017;48:114-21. [PMID: 28965008 DOI: 10.1016/j.coi.2017.08.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
15 Doyle AD, Masuda MY, Kita H, Wright BL. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions. Front Immunol 2020;11:603295. [PMID: 33335531 DOI: 10.3389/fimmu.2020.603295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Weller PF, Spencer LA. Functions of tissue-resident eosinophils. Nat Rev Immunol. 2017;17:746-760. [PMID: 28891557 DOI: 10.1038/nri.2017.95] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 35.2] [Reference Citation Analysis]
17 Dellon ES. The pathogenesis of eosinophilic esophagitis: beyond the eosinophil. Dig Dis Sci 2013;58:1445-8. [PMID: 23625288 DOI: 10.1007/s10620-013-2679-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
18 Cheng E. Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice. Curr Treat Options Gastroenterol. 2015;13:30-46. [PMID: 25598233 DOI: 10.1007/s11938-014-0041-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
19 Leung J, Beukema KR, Shen AH. Allergic mechanisms of Eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol 2015;29:709-20. [PMID: 26552770 DOI: 10.1016/j.bpg.2015.09.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
20 Xenakis JJ, Howard ED, Smith KM, Olbrich CL, Huang Y, Anketell D, Maldonado S, Cornwell EW, Spencer LA. Resident intestinal eosinophils constitutively express antigen presentation markers and include two phenotypically distinct subsets of eosinophils. Immunology. 2018;154:298-308. [PMID: 29281125 DOI: 10.1111/imm.12885] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]